Unlock Your Global Business Potential: Supporting Life Sciences in the UK
|
|
- Loren Ferguson
- 7 years ago
- Views:
Transcription
1 Unlock Your Global Business Potential: Supporting Life Sciences in the UK Dr Mark Treherne, Chief Executive, Life Science Investment Organisation Health Research Authority 31 st March, 2014 THE UK HAS THE MOST OPEN AND BUSINESS-ORIENTATED ECONOMY OF EUROPE, WITH THE MOST FLEXIBLE LABOUR MARKETS, AND THE LEAST RESTRICTIVE SYSTEMS 1
2 UK Government s Commitment to the Life Science Sector In December 2011 I made a firm commitment to re-establish the UK's global leadership in the life science sector, announcing the Government's ten-year Strategy for UK Life Sciences. By more closely integrating the UK's unique strengths, I believe that we can improve healthcare for patients, attract new investment to the UK, and create new jobs and business opportunities in an increasingly competitive and international industry. David Cameron Prime Minister Life Science Strategy is the UK s response to a global sector under pressure
3 The UK Ecosystem: Connect, Research, Develop, Validate, and Export The UK s increasingly integrated biomedical ecosystem is underpinned by: A supportive business environment An open and flexible regulatory framework Simplified industry access points Global connectivity and export potential
4 A Business Environment that Supports and Rewards Innovation The UK government has introduced fiscal measures to stimulate innovation and growth for companies: Patent box: 10% corporation tax on qualifying profits R&D tax credits: Up to 27p back per 1 spent 300 million UK Research Partnership Investment Fund 180 million Biomedical Catalyst Regional funding and incentives
5 Private Funding in the UK
6 Providing Access to Drive Healthcare Innovation: Active Partnership Between Academia, Industry, and the NHS Industry can leverage the UK as an innovation partner to develop an evidence base, supporting market access, uptake and diffusion in the UK and around the world In Northern Ireland: Connected Health and Prosperity Action Plan ensures cross-sectorial support for R&D and technology adoption In Scotland: Academic Health Sciences Collaboration facilitates partnerships between universities and health boards In England: In Wales: Academic Health Science Collaboration maximises links between health boards, trusts, universities and industry Academic Health Science Centres open up routes to market Biomedical Research Centres and Units link universities and NHS trusts Academic Health Science Networks will work with industry and drive adoption across the NHS in England
7 Unlocking Data to Drive Innovation In the UK, your business will have access to unrivalled, clinically-coded health data and biorepositories, including linked datasets to understand care pathways More than 60 million people are served by a National Health System Example data resources: UK Biobank is a unique resource of data and samples linked to medical histories and health records from 500,000 adult participants Clinical Practice Research Datalink (CPRD) enables observational studies, clinical trial feasibility and protocol optimisation, and postmarket surveillance NIHR BioResource enables recall to clinical studies by genotype and phenotype and helps stratify and select patients for trials
8 Growing Global Market for Stratified Medicine By 2020, the pharmaceutical industry will invest as much as 20% of its R&D budget in genetics and genomics 1 In oncology: Companion diagnostic tests like Her2 generate significant annual revenues 2 Market value of targeted cancer therapeutics over $40bn and growing Market for biomarkers for drug discovery and clinical trials is more than $1bn 2 The UK has prepared for and understands this shift, and is rapidly adapting to support industry success in stratified medicine 1=PriceWaterhouseCooper; 2=BCC Research
9 As part of a long term strategy, the UK is investing to develop stratified medicine capabilities and support industry success
10 UK Opportunity in Stratified Medicine: Consumer of research tools, platform technologies, and informatics solutions Example: The UK plans to undertake whole genome sequencing of up to 100,000 NHS patients over the next 3-5 years Partnership with industry combining research and clinical delivery Example: Cancer Research UK Stratified Medicine Programme Test-bed for products and services With 60+ million patients across the National Health Service, the UK offers a sizeable domestic opportunity UK can help your business demonstrate clinical and commercial proof of concept and support export opportunities
11 UK Stratified Medicine: Rich and Diverse Ecosystem First-class research and expertise Understand disease biology, develop or implement stratification tools, find expertise in genomics to advanced diagnostics Research and innovation funders and charities World-leading data and translational infrastructure NHS serving more than 60 million patients Industry access points and dedicated networks for R&D and clinical delivery Established value and supply chain Thriving industry base with deep expertise Expert suppliers, service providers, and collaborators
12 Creating an Open and Flexible Regulatory Framework Government commitments: Opening up the NHS to collaborate with your business on research and adoption Ensuring that products and services are critically appraised to the highest standard Transparent expert advice to support decisions on access to personal health information A streamlined health research approvals process Globally-respected regulators: The UK is home to the MHRA and the EMA Earlier Access and, potentially, Adaptive Licensing An expert stakeholder group meets quarterly to discuss regulatory innovation MHRA recently established an Innovation Office to promote early dialogue between the MHRA and companies developing innovative products including: advanced therapies, stratified medicines, nanotechnology, advanced manufacturing, and novel drug/device combinations
13 Year-on year improvement (reduction) in times to review all applications Time to complete review, all application types, England
14 Steady increase in uptake of Proportionate Review since introduction 700 Trends of Applications and Review Types Full Review 200 Proportionate Review Apr-2010 Apr-2011 Apr-2012 Apr-2013
15 Mean time to complete Full Review is stable at less than 35 days. PR is stable at less than 12 days
16 Long-term downward trend in the use of Provisional Opinions Increase in the use of Favourable with Additional Conditions
17 Less than 6% of applications receive an Unfavourable final opinion Final Decisions (UK) % 21.7% 11.9% 5.5% 6.7% Favourable Favourable with AC FIFO FIFO with AC FIUO Unfavourable 0.3%
18 Creating an Open and Flexible Regulatory Framework Government commitments: Opening up the NHS to collaborate with your business on research and adoption Ensuring that products and services are critically appraised to the highest standard Significant improvements in times to review all application types
19 19
Summary of the role and operation of NHS Research Management Offices in England
Summary of the role and operation of NHS Research Management Offices in England The purpose of this document is to clearly explain, at the operational level, the activities undertaken by NHS R&D Offices
More informationLife Science Sector Opportunities Northern Ireland. Clinical Trials. investni.com
Life Science Sector Opportunities Northern Ireland investni.com Introduction Clinical trials commonly refer to testing the effectiveness of experimental drugs and are typically categorised into four phases;
More informationUnlock Your Global Business Potential UK Stratified Medicine
Unlock Your Global Business Potential UK Stratified Medicine Contents The UK s Commitment to 02 Stratified Medicine UK Market Opportunities 04 Ease of Doing Business 07 Rich and Diverse Ecosystem 09 Research
More informationThe NHS as a Driver for Growth. A report by The Prime Minister s Council for Science and Technology
The NHS as a Driver for Growth A report by The Prime Minister s Council for Science and Technology September 2011 The NHS as a Driver for Growth The 21 st Century is bringing a revolution in the life sciences,
More informationTHE LINCOLN INSTITUTE OF HEALTH
THE LINCOLN INSTITUTE OF HEALTH Background The Chair in the Care of the Older Person will be part of the new Lincoln Institute of Health, a cross disciplinary research collaboration linking schools, colleges
More informationNavigating England s clinical research infrastructure. How NOCRI helps simplify access to accelerate discoveries
Navigating England s clinical research infrastructure How NOCRI helps simplify access to accelerate discoveries 2» The National Institute for Health Research (NIHR) Clinical Research Network recruited
More informationTranslational research facilitating experimental medicine in dementia in the UK
Translational research facilitating experimental medicine in dementia in the UK Simon Lovestone Director Biomedical Research Unit for dementia at Maudsley and King s Route Map for Dementia Research June
More informationResearch is everybody s business
Research and Development Strategy (DRAFT) 2013-2018 Research is everybody s business 1 Information Reader Box to be inserted for documents six pages and over. (To be inserted in final version, after consultation
More informationOffice for. Life Sciences. Strategy for UK. Life Sciences
Strategy for UK Life Sciences Office for Life Sciences Front page image: The i-limb ultra from Touch Bionics Contents Ministerial Foreword 2 Summary of key actions 3 1 Introduction 4 2 Building a life
More information4.11 Healthcare Technology Co-operatives Version 4 (July 2015)
HEALTHCARE TECHNOLOGY CO-OPERATIVES Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out
More informationMediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015
19th of March 2015 MediSapiens Ltd Because data is not knowledge Bio-IT solutions for improving cancer patient care Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2015 MediSapiens Ltd. All
More informationMedical research charities and the NHS - how can we get the best for patients?
Medical research charities and the NHS - how can we get the best for patients? Dr Liz Philpots, head of research 2015 Annual NHS R&D forum 5-6 May 2015 overview getting the best for patients scene setting
More informationForeword. Stephen Whitehead, Chief Executive, ABPI. Rt Hon Earl Howe, Parliamentary Under Secretary for Quality, Department of Health
Big data road map Foreword Rt Hon Earl Howe, Parliamentary Under Secretary for Quality, Department of Health Rt Hon David Willetts MP, Minister for Universities and Science, Department for Business, Innovation
More informationThe stratification of disease for personalised medicines
The stratification of disease for personalised medicines Research driven recommendations to strengthen a unified UK strategy through a stakeholder alliance Vision paper, September 2014 Update to White
More informationCPRD Clinical Practice Research Datalink john.parkinson@cprd.com Scotland Meeting May 2012
CPRD Clinical Practice Research Datalink john.parkinson@cprd.com Scotland Meeting May 2012 Computational Biochemist PhD Liverpool Pharma Healthcare Food Advertising JWT Healthcare Medical Education UoD
More informationResearch and Innovation Strategy: delivering a flexible workforce receptive to research and innovation
Research and Innovation Strategy: delivering a flexible workforce receptive to research and innovation Contents List of Abbreviations 3 Executive Summary 4 Introduction 5 Aims of the Strategy 8 Objectives
More informationHouse of Lords Select Committee on Science and Technology: Regenerative Medicine
House of Lords Select Committee on Science and Technology: Response by the Wellcome Trust Key Points The UK needs to maintain support for basic research in all avenues of regenerative medicine research,
More informationRevision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices. Response from Cancer Research UK to the Commission August 2010
Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices Response from Cancer Research UK to the Commission August 2010 1. Cancer Research UK (CR-UK) 1 is leading the world in finding
More informationA competency framework for all prescribers updated draft for consultation
A competency framework for all prescribers updated draft for consultation Consultation closes 15 April 2016 Contents 1 Introduction... 3 2 Uses of the framework... 4 3 Scope of the competency framework...
More informationCall for Demonstrator Projects
Association of the British Pharmaceutical Industry 7th Floor, Southside, 105 Victoria Street, London SW1E 6QT t +44 (0)870 890 4333 www.abpi.org.uk Call for Demonstrator Projects ABPI Big Data Demonstrators
More informationBig Data for Population Health
Big Data for Population Health Prof Martin Landray Nuffield Department of Population Health Deputy Director, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery University of Oxford
More informationAttributing the costs of health and social care Research and Development (AcoRD)
Attributing the costs of health and social care Research and Development (AcoRD) Page 1 of 8 Contents Contents. 2 Purpose.. 3 Background. 3 Basic Principles.. 4 Commercial Contract Studies.. 4 Non-commercial
More informationBest research for best practice: policy and practice in clinical research nursing. RCN Research Society Supported by Nurse Researcher
Best research for best practice: policy and practice in clinical research nursing RCN Research Society Supported by Nurse Researcher Understand new research infrastructures and opportunities within the
More informationThe Health Research Authority. Janet Wisely. April 2015
The Health Research Authority Janet Wisely April 2015 The HRA as an organisation A Non-Departmental Public Body January 2015 Public sector employees on NHS terms Volunteer members of committees A Special
More information360 of Health Data: Harnessing big data for better health
360 of Health Data: Harnessing big data for better health Preface With the explosive growth in health and biomedical data, the big data era has arrived in medicine. We are beginning a transformational
More informationIndustry Engagement in Wales
Sefydliad Cenedlaethol ar gyfer Ymchwil Gofal Cymdeithasol ac Iechyd National Institute for Social Care and Health Research Industry Engagement in Wales The National Institute for Social Care and Health
More informationConnected Health (Priority Area D)
PRIORITY AREA D: CONNECTED HEALTH ACTION PLAN Connected Health (Priority Area D) Context Connected health and independent living technologies are technologies that facilitate remote delivery of healthcare
More informationThe 100,000 genomes project
The 100,000 genomes project Tim Hubbard @timjph Genomics England King s College London, King s Health Partners Wellcome Trust Sanger Institute ClinGen / Decipher Washington DC, 26 th May 2015 The 100,000
More informationHow To Improve Your Business
Corporate plan 2015 2016 Page 1 Introduction The Nursing and Midwifery Council is the professional regulatory body for nurses and midwives in the UK. Our purpose is to protect the public through efficient
More informationBusiness Support for SMEs Maximising the Value of Intellectual Property
Business Support for SMEs Maximising the Value of Intellectual Property Intellectual Property Office is an operating name of the Patent Office Contents Introduction 1 Business Support Programmes 2 Design
More informationDoes my project require review by a Research Ethics Committee?
National Research Ethics Service Does my project require review by a Research Ethics Committee? This algorithm is designed to assist researchers, sponsors and R&D offices in determining whether a project
More informationThe Government plan for a secure data service
The Government plan for a secure data service Strengthening the international competitiveness of UK life 1 The Government plan for a secure data service: Strengthening the international competitiveness
More informationInformatics: The future. An organisational summary
Informatics: The future An organisational summary DH INFORMATION READER BOX Policy HR/Workforce Management Planning/Performance Clinical Document Purpose Commissioner Development Provider Development Improvement
More informationTitle. Enterprise Europe Network & Innovate UK
Enterprise Europe Network & Innovate UK Title Practical help for small and medium businesses engaged with research & innovation. Sub-title Roger Hetherington 9 th December 2014 PLACE PARTNER S LOGO HERE
More informationMedical Devices (Priority Area E) Context
PRIORITY AREA E: MEDICAL DEVICES ACTION PLAN Medical Devices (Priority Area E) Context The global medical device market was reported as $296 billion in 2010. Growth varies from 3-9 per cent per annum depending
More informationCANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE
CANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE Agenda Introduction to Cancer Research UK CRUK Stratified Medicine Programme Key Challenges and Lessons
More informationIndustrial Strategy: government and industry in partnership. Strategy for UK Life Sciences. One Year On
Industrial Strategy: government and industry in partnership Strategy for UK Life Sciences One Year On Contents Prime Minister s foreword 2 Ministerial foreword 3 Update from the Life Science Champions
More informationWhat Lies Ahead? Trends to Watch: Health Care Product Development in North America
What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? for 2015 DIA has released its third annual What Lies Ahead? report, providing experts insights into the
More informationHow To Change Medicine
P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything Leroy E. Hood Institute for Systems Biology David J. Galas Battelle Memorial Institute Version
More informationMedicines and Healthcare products Regulatory Agency
Medicines and Healthcare products Regulatory Agency 11 April 2016 Update on progress with the Joint Patient Safety and Vigilance Strategy Purpose: This paper provides the Board with an update on the Joint
More informationCharacteristics of the UK Research Base: high performance
UK Research Characteristics of the UK Research Base: high performance Citations (all sectors) per unit spend on GERD for UK and comparators (2008-12) Source: Field-Weighted Citation Impact (FWCI) Elsevier
More informationTriennial Review of NHS Blood and Transplant (NHSBT) A Review of NHS Blood and Transplant (NHSBT) Call for Evidence
Triennial Review of NHS Blood and Transplant (NHSBT) A Review of NHS Blood and Transplant (NHSBT) Call for Evidence August 2015 Title: Triennial Review of NHS Blood and Transplant Call for Evidence Author:
More informationResearch strategy and capacity development in population health science: an MRC and personal view
Research strategy and capacity development in population health science: an MRC and personal view Professor Anne Johnson, UCL Former Chair, MRC Population Health Sciences Strategy Group Foci of MRC and
More informationEU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE
EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE Purpose 1. The Clinical Trials Directive 2001/20/EC heralds certain additional responsibilities for the Medicines and Healthcare
More informationPUBLIC HEALTH WALES NHS TRUST CHIEF EXECUTIVE JOB DESCRIPTION
PUBLIC HEALTH WALES NHS TRUST CHIEF EXECUTIVE JOB DESCRIPTION Post Title: Accountable to: Chief Executive and Accountable Officer for Public Health Wales NHS Trust Trust Chairman and Board for the management
More informationBOOSTING THE COMMERCIAL RETURNS FROM RESEARCH
BOOSTING THE COMMERCIAL RETURNS FROM RESEARCH Submission in response to the Discussion Paper November 2014 Page 1 ABOUT RESEARCH AUSTRALIA is an alliance of 160 members and supporters advocating for health
More informationStrength and Opportunity. The landscape of the medical technology, medical biotechnology and industrial biotechnology sectors in the UK
Strength and Opportunity The landscape of the medical technology, medical biotechnology and industrial biotechnology sectors in the UK Annual Update December 2010 Cover photo is from the UKTI Life Sciences
More informationPolicy statement. Stem cell research
Policy statement Stem cell research Introduction For some people who survive a heart attack, the damage to their heart muscle can lead to debilitating heart failure, for which there is no cure. Nearly
More informationGovernment support for charity funded research in universities A joint statement from universities and charities in the UK i
Government support for charity funded research in universities A joint statement from universities and charities in the UK i We call on the Government to reaffirm its commitment to ongoing partnership
More informationNMC Standards of Competence required by all Nurses to work in the UK
NMC Standards of Competence required by all Nurses to work in the UK NMC Standards of Competence Required by all Nurses to work in the UK The Nursing and Midwifery Council (NMC) is the nursing and midwifery
More informationA leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
More informationResearch Strategy 2012 2020
Research Strategy 2012 2020 Foreword Acknowledgements We are particularly indebted to Professor David Neal and Professor Michael Olson for their expert assessment of the trends, gaps and bottlenecks in
More informationBirmingham Professional Forum
Birmingham Professional Forum Lee Sanders, Registrar and Secretary 2 April 2015 Agenda Introduction - Lee Sanders An introduction to Chris Granger, Director of Finance Higher Education Review - Professor
More informationPharmacovigilance and the Internet: A Call for Change
Pharmacovigilance and the Internet: A Call for Change A white paper from the ABPI Pharmacovigilance Expert Network 13 June 2011 Page 2 of 6 Pharmacovigilance and the Internet: A Call for Change (ABPI)
More informationUniversity Medical Centres
University Medical Centres in the Netherlands AMC UMC Utrecht University Medical Centres University Medical Centres and the Health System Reform in the Netherlands: a Position Paper In the last ten years
More informationMedicines and Healthcare Products Regulatory Agency Business Plan 2014-15
Medicines and Healthcare Products Regulatory Agency Business Plan 2014-15 1 Contents 1. Introduction 2. Financial context 3. Key strategic activities for 2014-15: - Vision and scope of our work - Bringing
More informationBig Data An Opportunity or a Distraction? Signal or Noise?
Big Data An Opportunity or a Distraction? Signal or Noise? Maya R. Said, Sc.D. SVP & Global Head, Oncology Policy & Market Access, Novartis 3rd International Systems Biomedicine Symposium Luxembourg, 28
More informationMedical Technology - Industry Assistance in Queensland. 30 May 2014
Medical Technology - Industry Assistance in Queensland 30 May 2014 0 mtaa.org.au Medical technology for a healthier Australia www.mtaa.org.au Level 12, 54 Miller St, North Sydney NSW 2060 Australia PO
More informationAttributing the costs of Health and Social Care Research & Development (AcoRD)
HSC R&D Division Attributing the costs of Health and Social Care Research & Development (AcoRD) Contents Contents... 2 Purpose... 3 Background... 3 Basic Principles...4 Commercial Contract Studies...4-5
More informationMPA/MPS PROCUREMENT STRATEGY 2009-12 TO BE THE UK LEADER IN PUBLIC SECTOR PROCUREMENT
MPA/MPS PROCUREMENT STRATEGY 2009-12 TO BE THE UK LEADER IN PUBLIC SECTOR PROCUREMENT CONTENTS Foreword ------------------------------------------------------------------------ 3 Executive Summary ---------------------------------------------------------
More informationPARTICIPANT INFORMATION
PARTICIPANT INFORMATION IMPERIAL POPULATION BIORESOURCE TISSUE BANK (PART OF NIHR BIORESOURCE) In the UK around 20 million people are said to be living with a long-term condition such as diabetes or heart
More informationInformatics: Opportunities & Applications. Professor Colin McCowan Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit
Informatics: Opportunities & Applications Professor Colin McCowan Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit Routine Data "routine data" is data collected as byproducts of clinical
More informationDeveloping a database to support patient and public engagement (PPE) A DH PPI pathfinder project with Leeds South and East CCG
Developing a database to support patient and public engagement (PPE) A DH PPI pathfinder project with Leeds South and East CCG MSDi Overview History Established in 2000 by MSD to leverage emerging informatics
More informationQUALITY AND INTEGRATED GOVERNANCE BUSINESS UNIT. Clinical Effectiveness Strategy (Clinical Audit/Research) 2013-2015
Southport and Ormskirk Hospital NHS Trust QUALITY AND INTEGRATED GOVERNANCE BUSINESS UNIT Clinical Effectiveness Strategy (Clinical Audit/Research) 2013-2015 Any practitioner who is using research-based
More informationNational Initiatives Impacting Healthcare Information Technology (HCIT) in the United Kingdom ehealth Action Plan to Increase HCIT Market Maturity
National Initiatives Impacting Healthcare Information Technology (HCIT) in the United Kingdom ehealth Action Plan to Increase HCIT Market Maturity January 2015 Contents Section Slide Number Executive Summary
More informationOverview of the EHR4CR project Electronic Health Record systems for Clinical Research
Overview of the EHR4CR project Electronic Health Record systems for Clinical Research Dipak Kalra UCL on behalf of the EHR4CR Consortium ENCePP Plenary Meeting, 3rd May 2012, London The problem (as addressed
More informationIndustry Growth Centres Initiative
Industry s Initiative Long term prosperity will depend on the ability of Australian industry to be more innovative, productive and competitive in order to capture the opportunities from a growing global
More informationTaking Part in Research at University Hospitals Birmingham
University Hospitals Birmingham NHS Foundation Trust The Trust provides free monthly health talks on a variety of medical conditions and treatments. For more information visit www.uhb.nhs.uk or call 0121
More informationHealthcare Innovation in the UK - A Royal Society of Chemistry Position Paper
Healthcare Innovation in the UK - A Royal Society of Chemistry Position Paper Introduction The pharmaceutical industry (Pharma) has made important contributions to quality of life, longevity, economic
More informationStudy-wide considerations: identifies the areas of the criterion the lead reviewer should consider when conducting the review
UK STUDY-WIDE GOVERNANCE CRITERIA FOR R&D REVIEW INTRODUCTION The following document is intended to provide operational guidance to the person taking the UK lead in conducting the R&D Study-Wide review
More information3.7% Historical trends in the UK. by Therese Lloyd. January 2015 FUNDING OVERVIEW
FUNDING OVERVIEW January 2015 Historical trends in the UK by Therese Lloyd SEE BRIEFING: NHS Finances The challenge all political parties need to face www.health.org.uk/ fundingbriefing In real terms,
More informationA Health and Social Care Research and Development Strategic Framework for Wales
IMPROVING HEALTH IN WALES A Health and Social Care Research and Development Strategic Framework for Wales a consultation document February 2002 Please send your comments by 17 May 2002 to: Gerry Evans
More informationThe Cell Therapy Catapult
The Cell Therapy Catapult Keith Thompson CEO January 29 2013 info@ct.catapult.org.uk Catapult is a Technology Strategy Board programme The Launch of Catapults Hauser 2 Hauser Report Creating new manufacturing
More informationTACD RECOMMENDATIONS ON HEALTH CARE AND INTELLECTUAL PROPERTY AND EUROPEAN COMMISSION SERVICES RESPONSES
TRANSATLANTIC CONSUMER DIALOGUE WASHINGTON MEETING, 10-12 FEBRUARY 2000 TACD RECOMMENDATIONS ON HEALTH CARE AND INTELLECTUAL PROPERTY AND EUROPEAN COMMISSION SERVICES RESPONSES The Commission Services
More informationCONSULTATION RESPONSE
CONSULTATION RESPONSE Department for Business, Innovation and Skills (BIS): Regenerative Medicine Call for Evidence Response by the Wellcome Trust Introduction 1. The Wellcome Trust is pleased to have
More informationMSD Information Technology Global Innovation Center. Digitization and Health Information Transparency
MSD Information Technology Global Innovation Center Digitization and Health Information Transparency 10 February 2014 1 We are seeking energetic, forward thinking graduates to join our Information Technology
More informationToday s Health Research Is Tomorrow s Healthcare
Medical Research Charities Group La Touche House, 1 Grove Road, Dublin 6. Today s Health Research Is Tomorrow s Healthcare Medical Research Charities Group Pre-Budget Submission Budget 2011 The future
More informationKeystones for supporting collaborative research using multiple data sets in the medical and bio-sciences
Keystones for supporting collaborative research using multiple data sets in the medical and bio-sciences David Fergusson Head of Scientific Computing The Francis Crick Institute The Francis Crick Institute
More informationResearch. Evidence. Our mission: and to improve healthcare delivery. Delivering future health
Research. Our mission: Evidence. to improve Action. people s HRB Strategy health 2016-2020 and to improve healthcare delivery Delivering future health HRB Strategy 2016-2020 We will lead and support excellent
More informationFunding New Innovations in Synthetic Biology
Funding New Innovations in Synthetic Biology Dr Belinda Clarke Lead Technologist, Synthetic Biology email: belinda.clarke@tsb.gov.uk twitter: @Belinda_Clarke Janus Transitions and change The past and the
More informationAccelerating Development and Approval of Targeted Cancer Therapies
Accelerating Development and Approval of Targeted Cancer Therapies Anna Barker, NCI David Epstein, Novartis Oncology Stephen Friend, Sage Bionetworks Cindy Geoghegan, Patient and Partners David Kessler,
More informationNATIONAL INFORMATION BOARD. WORK STREAM 1.2 ROADMAP Enable me to make the right health and care choices
NATIONAL INFORMATION BOARD Personalised Health and Care 2020 WORK STREAM 1.2 ROADMAP Enable me to make the right health and care choices Providing citizens with access to an assessed set of NHS and social
More informationROY CASTLE LUNG CANCER FOUNDATION
ROY CASTLE LUNG CANCER FOUNDATION Cancer research spend in the UK 2002 2011 An overview of the research funded by NCRI Partners Permission to reproduce The text included within this publication may be
More informationKey considerations for outsourcing late phase clinical research
Key considerations for outsourcing late phase clinical research Alan Nelson (on behalf of Van Zyl Engelbrecht) Senior Project Director at UBC: An Express Script Company Layout of presentation My presentation
More informationCLINICAL RESEARCH NETWORK
CLINICAL RESEARCH NETWORK Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the
More informationIl ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020
Il ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020 Lucia Monaco Horizon 2020 Advisory Group, Societal Challenges 1: Health, Demographic Change and Wellbeing Seminario:
More informationThe Research Capability Programme. Peter Knight, Group Programme Director
The Research Capability Programme Peter Knight, Group Programme Director 11/03/2010 RESEARCH FOR PATIENT BENEFIT WORKING PARTY FINAL REPORT For us, science and research constitute a front-line service,
More informationTHE UNIVERSITY OF MANCHESTER PARTICULARS OF APPOINTMENT FACULTY OF MEDICAL & HUMAN SCIENCES INSTITUTE OF POPULATION HEALTH
THE UNIVERSITY OF MANCHESTER PARTICULARS OF APPOINTMENT FACULTY OF MEDICAL & HUMAN SCIENCES INSTITUTE OF POPULATION HEALTH CENTRE FOR HEALTH INFORMATICS HEALTH DATA SCIENTIST Vacancy ref: M&HS-07879 Salary:
More informationCreating Change IHW One Year On
Creating Change IHW One Year On Foreword When I published Innovation Health and Wealth, accelerating adoption and diffusion in the NHS (IHW) in December 2012, I said that innovation must become core business
More informationLIFE & HEALTH SCIENCES NORTHERN IRELAND
February 2015 LIFE & HEALTH SCIENCES NORTHERN IRELAND Capability Assessment & Foresight Report WWW.MATRIXNI.ORG FOREWORD The life and health sciences sector in Northern Ireland has burgeoning potential.
More informationStrategy 2012 2015. Providing resources for staff and students in higher and further education in the UK and beyond
Providing resources for staff and students in higher and further education in the UK and beyond Strategy 2012 2015 EDINA is a JISC National Datacentre Table of Contents Introduction... 1 Vision... 1 Mission
More informationTherapeutics Industry Participation in P4P The Value Proposition
Therapeutics Industry Participation in P4P The Value Proposition Alex Ruggieri, MD MHS Chief Medical Officer Senior Director Safety Solutions Cerner Galt Cerner Corporation Beverly Hills, California The
More informationThe Board reviews risks to the Company s business plan at its scheduled meetings.
Pharmaxis Ltd 1. Board responsibility The Pharmaxis Board is responsible for ensuring the Company establishes and maintains a risk management framework for the oversight and management of risk. The Board
More informationNational Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) Operating Manual Please check the CRN Website for the latest version. Version: 6.0 Status: Consultation in
More informationResearch Design Service London
Research Design Service London Enabling Better Research Peter Lovell Programme Manager 27 th October 2011 Overview of presentation An introduction to the NIHR Research Design Service (RDS) Outline of the
More informationMoffitt Cancer Center, M2Gen and ConvergeHEALTH Collaboration
Moffitt Cancer Center, M2Gen and ConvergeHEALTH Collaboration Eric Padron, M.D., Section Head, Personalized Medicine and Genomics, Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute
More informationConsultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics
Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics Response by the Genetic Interest Group Question 1: Health
More informationNIHR University College London Hospitals Biomedical Research Centre. Progress on implementing our revised strategic plan
NIHR University College London Hospitals Biomedical Research Centre Progress on implementing our revised strategic plan NIHR University College London Hospitals Biomedical Research Centre At the NIHR University
More informationSouth Australia. The place where people and business thrive.
South Australia. The place where people and business thrive. Premier s statement South Australia is the place where people and business thrive. That is my vision for this great state. South Australia is
More informationReport Update on National Research Funding July 2014
Report Update on National Research Funding July 214 1 in 5 people who die under the age of 6 die of 1 a brain tumour With one in 5 people who die under the age of 6 (from all causes) dying of a brain tumour
More information